| 摘要 |
The present invention refers to the formulation or combination of two compounds, being one of them an bronchodilator known as salbutamol and the other an antiallergic histamine H1-receptor antagonist antiallergic known as azelastina, which are formulated in aerosol for inhalation. The combination of these substances produces as a result a bronchodilator, antiallergic and anti-inflammatory effect, at the specific action area.
|
